Dyne Therapeutics

Dyne Therapeutics

Associate Director, Financial Planning & Analysis (FP&A)

Waltham, MA · Director

Sponsorship not specified$170k-$195kDetected 16 days ago
Financial ModelingFinancial AnalysisAccountingForecastingBudgetingExcelFP&AAnimal StudiesCommunicationProblem SolvingFinancial ReportingVariance Analysis

Stay score

odds of building a lasting career here

59Sponsors, lottery-bound
Cap-exempt (no lottery)0
Sponsors this role80
Entry-level history0
PERM / green-card track0
Lottery odds (Level IV)94
Fits your clock70

Sponsors, but it's cap-subject — you still face the weighted lottery (~61% per draw at Level IV). Good if you win; have a cap-exempt backup on your list.

Lottery odds assume a STEM candidate.

Personalize to your clock →

H-1B wage level

the lottery is wage-weighted — each level is one more entry

Level I · 1×
Level I$137,2381 entry
Level II$179,3172 entries
Level III$221,3743 entries
Level IV$263,4534 entries

$9,317 more — $179,317 — moves this role to Level II and 2 lottery entries. That figure is inside the range the employer already advertised.

Based on the DOL prevailing wage for this occupation and worksite, a base salary of $179,317 would place this position at wage Level II. That figure is within the posted range, and I'd like to target it. This role classifies under "Financial Managers" for prevailing-wage purposes.

DOL prevailing wage, 2026-27 wage year · Financial Managers (11-3031) · Boston-Cambridge-Newton, MA-NH. Wage level is derived by USCIS from the offered wage, occupation and worksite; the occupation shown is inferred from the job title.

Employer immigration record

from this employer's Department of Labor filings

Files H-1B transfers

2 transfer filings in the last year, covering 2 workers. Median labor-condition decision: 8 days. An employer that already files transfers is one that can take over an existing H-1B.

Sourced from Department of Labor LCA, PERM and prevailing-wage disclosure data. Employer matching is by name, so figures may be split across an employer's legal entities. Absence of a filing means none appears in our copy of the data, not that none exists.

Community outcomes

No reports yet — be the first to help the next applicant.

About the role

  • Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases.
  • The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations.
  • Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.

Requirements

  • 8+ years of progressive experience in FP&A, corporate finance, business analysis, or related financial roles, preferably within biotechnology, pharmaceuticals, life sciences, or a growth-stage public company environment.
  • Expertise in financial modeling, scenario analysis, variance analysis, and business performance management.
  • Experience administering and optimizing financial planning, reporting, business intelligence, and enterprise financial systems.
  • Experience working with financial data warehouses and partnering with IT teams on reporting and systems enhancement initiatives.
  • Strong understanding of financial statements, including P&L, balance sheet, and cash flow analysis.
  • Strong analytical, problem-solving, and critical-thinking skills with the ability to translate complex financial information into actionable business insights.
  • Advanced proficiency with Microsoft Excel and financial planning/reporting systems.

Nice to have

  • Bachelor's degree in Finance, Accounting, Economics, Business Administration, or a related discipline
  • MBA, CPA, or other advanced degree/certification preferred.

Skills

  • Monitor budget versus actual performance and provide variance analysis, insights, and recommendations to business leaders.
  • Conduct scenario planning and investment analyses, including evaluation of resource allocation and buy-up investment opportunities.
  • Ensure data integrity, consistency, and usability across financial planning and reporting platforms.
  • Review contracts and purchase requisitions to ensure alignment with approved budgets, financial policies, and forecast assumptions.
  • Monitor and report on key performance indicators (KPIs) and business performance metrics.
  • Assist in the preparation of financial materials for Audit Committee and Board of Directors meetings.
  • Identify opportunities to improve financial processes, reporting efficiency, data quality, and planning capabilities.

Compensation

  • Collaborate with cross-functional teams to develop quarterly forecasts, annual budgets, and short- and long-range financial plans.

Company info

  • We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease.
  • At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities.

This listing is sourced directly from Dyne Therapeutics's careers page and normalized into a canonical job model.